Two of our members, Anne Rosser and Anne-Catherine Bachoud-Levi, will participate to the virtual event organized by the European Huntington's Disease Network (EHDN) on September 11 (registration here). They will give their perspective on the challenges faced by the clinical studies conducted on potential HD treatments using stem cells. The complete programme can be found here.
Comments